BACKGROUND: Reelin is a large extracellular glycoprotein that is present in the peripheral blood. That Reelin interacts with the coagulation components and elicits a functional role in hemostasis has not yet been elucidated. OBJECTIVES: The hemostatic activity of Reelin is investigated and defined in this study. METHODS: The interplay of Reelin with coagulation components was elucidated by far-Western and liposome/platelet binding assays. In vivo and ex vivo hemostasis-related analyses of Reelin-deficient mice and plasma were also performed. RESULTS: Reelin interacted with the liposomes containing phosphatidylserine (PS) or phosphatidylcholine. Instead of interacting with known Reelin receptors (ApoE receptor 2, very low density lipoprotein receptor and integrin β1), Reelin interacted with PS of the activated platelets. The interaction between Reelin and the coagulation factors of thrombin and FXa was also demonstrated with the Kd of 11.7 and 21.2 nm, respectively. Reelin-deficient mice displayed a prolonged bleeding time and an increase in rebleeding rate. Despite the fact that Reelin deficiency had no significant effect on the clotting time of prothrombin and activated partial thromboplastin time, the fibrin clot formation was abnormal and the fibrin clot structure was relatively loosened with reduced clot strength. Abnormal fibrinogen expression did not account for the hemostatic defects associated with Reelin deficiency. Instead, thrombin generation was impaired concomitant with an altered prothrombin cleavage pattern. CONCLUSIONS: By interacting with platelet phospholipids and the coagulation factors, thrombin and FXa, Reelin plays a selective role in coagulation activation, leading to thrombin generation and formation of a normal fibrin clot.
BACKGROUND:Reelin is a large extracellular glycoprotein that is present in the peripheral blood. That Reelin interacts with the coagulation components and elicits a functional role in hemostasis has not yet been elucidated. OBJECTIVES: The hemostatic activity of Reelin is investigated and defined in this study. METHODS: The interplay of Reelin with coagulation components was elucidated by far-Western and liposome/platelet binding assays. In vivo and ex vivo hemostasis-related analyses of Reelin-deficient mice and plasma were also performed. RESULTS:Reelin interacted with the liposomes containing phosphatidylserine (PS) or phosphatidylcholine. Instead of interacting with known Reelin receptors (ApoE receptor 2, very low density lipoprotein receptor and integrin β1), Reelin interacted with PS of the activated platelets. The interaction between Reelin and the coagulation factors of thrombin and FXa was also demonstrated with the Kd of 11.7 and 21.2 nm, respectively. Reelin-deficient mice displayed a prolonged bleeding time and an increase in rebleeding rate. Despite the fact that Reelin deficiency had no significant effect on the clotting time of prothrombin and activated partial thromboplastin time, the fibrin clot formation was abnormal and the fibrin clot structure was relatively loosened with reduced clot strength. Abnormal fibrinogen expression did not account for the hemostatic defects associated with Reelin deficiency. Instead, thrombin generation was impaired concomitant with an altered prothrombin cleavage pattern. CONCLUSIONS: By interacting with platelet phospholipids and the coagulation factors, thrombin and FXa, Reelin plays a selective role in coagulation activation, leading to thrombin generation and formation of a normal fibrin clot.
Authors: Yinyuan Ding; Linzhang Huang; Xunde Xian; Ivan S Yuhanna; Catherine R Wasser; Michael Frotscher; Chieko Mineo; Philip W Shaul; Joachim Herz Journal: Sci Signal Date: 2016-03-15 Impact factor: 8.192
Authors: Sarah L King; Christoffer K Goth; Ulrich Eckhard; Hiren J Joshi; Amalie D Haue; Sergey Y Vakhrushev; Katrine T Schjoldager; Christopher M Overall; Hans H Wandall Journal: J Biol Chem Date: 2018-03-28 Impact factor: 5.157
Authors: Elvira Khialeeva; Joan W Chou; Denise E Allen; Alec M Chiu; Steven J Bensinger; Ellen M Carpenter Journal: J Mammary Gland Biol Neoplasia Date: 2017-01-26 Impact factor: 2.673
Authors: Laurent Calvier; Guillaume Demuth; Navid Manouchehri; Connie Wong; Anastasia Sacharidou; Chieko Mineo; Philip W Shaul; Nancy L Monson; Maria Z Kounnas; Olaf Stüve; Joachim Herz Journal: Sci Transl Med Date: 2020-08-12 Impact factor: 17.956
Authors: Hector J Caruncho; Kyle Brymer; Raquel Romay-Tallón; Milann A Mitchell; Tania Rivera-Baltanás; Justin Botterill; Jose M Olivares; Lisa E Kalynchuk Journal: Front Cell Neurosci Date: 2016-02-25 Impact factor: 5.505